MAPT and Alzheimer disease: To date, there is no mouse model described that fully reflects all pathologies of human sporadic AD (Aβ plaques, tau/neurofibrillary tangles, neurodegeneration, vascular impairment, glial dysfunction, and inflammation) [70].